from the United States Court of Appeals for the Federal Circuit
See other cases from the Federal Circuit.
Petition DENIED.
Reply of petitioners Mylan Pharmaceuticals Inc., et al. filed.
Brief of respondents Eurand, Inc., nka Aptalis Pharmatech, Inc., et al. in opposition filed.
Brief amicus curiae of Generic Pharmaceutical Association filed.
Consent to the filing of amicus curiae briefs, in support of either party or of neither party, received from counsel for the respondents.
Consent to the filing of amicus curiae briefs, in support of either party or of neither party, received from counsel for Par Pharmaceuticals.
Consent to the filing of amicus curiae briefs received from either party or of neither party, received from counsel for petitioners.
Order extending time to file response to petition to and including December 11, 2012.
Petition for a writ of certiorari filed. (Response due November 26, 2012)
Mylan Pharmaceuticals Inc., et al., Petitioner, represented by James H. Wallace Jr.
Eurand, Inc., nka Aptalis Pharmatech, Inc., et al., Respondent, represented by Jonathan Singer
Generic Pharmaceutical Association, Amicus Curiae, represented by Robert L. Byer